Gene and Cell Therapy Scientists are pioneering a new era in medical treatments by developing innovative therapies that target the underlying causes of diseases at the genetic and cellular levels. These scientists utilize cutting-edge techniques like gene editing, viral vectors, and stem cell manipulation to repair, replace, or alter genetic material to treat or prevent diseases. Their work covers a wide range of conditions, from genetic disorders such as cystic fibrosis to cancers, autoimmune diseases, and even neurodegenerative diseases. By modifying the patient’s cells or genes, they aim to restore normal function or even eradicate diseases that were previously considered untreatable. In their work, gene and cell therapy scientists collaborate with multidisciplinary teams, including biologists, clinicians, and regulatory experts, to ensure that their therapies are both safe and effective. They focus on overcoming the challenges of delivering genes or engineered cells to the right locations in the body, managing immune responses, and scaling up production for clinical use. With the growing potential of personalized medicine, these scientists play a pivotal role in transforming laboratory findings into real-world, life-changing treatments. As the field progresses, gene and cell therapy scientists continue to push boundaries, offering new hope for patients suffering from chronic and genetic diseases, and reshaping the future of medicine.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia